XML 78 R64.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity - Stock Option Activities of Long-Term Incentive and Option Plans (Detail) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2016
Stockholders Equity [Line Items]        
Shares outstanding at beginning of year 124,000      
Cancelled, forfeited or expired, Shares (2,000)      
Shares outstanding at end of year 122,000 124,000    
Shares exercisable at end of year 122,000      
Outstanding at beginning of year, Weighted-Average Exercise Price $ 33.86      
Forfeited or expired, Weighted-Average Exercise Price 34.50      
Outstanding at end of year, Weighted-Average Exercise Price 33.85 $ 33.86    
Exercisable at end of year, Weighted-Average Exercise Price $ 33.85      
Stock-based compensation expense - Cost of sales $ 106,000 $ 122,000 $ 141,000  
Stock-based compensation expense - SG&A 42,000 50,000 71,000  
Income tax benefit (36,000) (42,000) (54,000)  
Total fair value of options vested during the year $ 180,000 $ 169,000 $ 169,000  
Total weighted-average remaining vesting period in years 0 years 5 months 26 days 1 year 18 days  
Total weighted-average remaining contractual life period in years (options outstanding) 2 years 7 months 20 days 3 years 7 months 9 days 4 years 7 months 9 days  
Total weighted-average remaining contractual life period in years (options exercisable) 2 years 7 months 20 days 3 years 5 months 19 days 4 years 3 months 21 days  
2016 Plan [Member]        
Stockholders Equity [Line Items]        
Granted, Shares 0 0 0  
Maximum number of securities for issuance 2,750,000      
Number of awards available to be granted 1,016,951     2,750,000
2016 Plan [Member] | Restricted Stock/Performance-Based Restricted Stock/Restricted Stock Units [Member]        
Stockholders Equity [Line Items]        
Number of unvested restricted stock/performance-based restricted stock/restricted stock units outstanding 1,169,527      
2008 Plan [Member]        
Stockholders Equity [Line Items]        
Shares outstanding at end of year 122,000      
Shares exercisable at end of year 122,000